Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques
Apoptosis and inflammation are important features of atherosclerotic plaques. We investigated whether a common signal molecule can trigger these two apparently separate pathways. Hypoxia inducible factor (HIF-1α) is known to participate in atherosclerosis and to stimulate apoptosis signal-regulating...
Saved in:
Published in | Journal of vascular surgery Vol. 52; no. 4; pp. 1015 - 1021 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Mosby, Inc
01.10.2010
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0741-5214 1097-6809 1097-6809 |
DOI | 10.1016/j.jvs.2010.05.116 |
Cover
Summary: | Apoptosis and inflammation are important features of atherosclerotic plaques. We investigated whether a common signal molecule can trigger these two apparently separate pathways. Hypoxia inducible factor (HIF-1α) is known to participate in atherosclerosis and to stimulate apoptosis signal-regulating kinase 1 (ASK-1), one of the mitogen-activated protein kinases, which is activated by various extracellular stimuli and involved in a variety of cellular function.
We tested carotid artery specimens from 50 subjects who underwent angioplasty and five age-matched controls for either Western blot or histologic analysis. The hypoxic status was investigated by means of HIF-1α expression in carotid specimens.
HIF-1α was significantly upregulated in carotid specimens with respect to controls (
P < .05), ASK-1 was detected in plaques of any composition from lipidic to calcific, and this expression increased with the stage of the plaque and with the expression of inflammatory (p-ERK, RANK-L, OPG) and apoptotic molecules (caspase 9, p-p-38, and p-JNK).
Our data suggest that hypoxia is the key regulating factor that triggers inflammation as well as apoptosis in the human atherosclerotic plaque.
This study adds evidence that HIF-1α is important in the oxidative stress response in the developing atherosclerotic plaque as it modulates both inflammatory and mitochondrion-related apoptotic pathways. Future therapy targeting HIF-1α may limit atherosclerosis development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0741-5214 1097-6809 1097-6809 |
DOI: | 10.1016/j.jvs.2010.05.116 |